M06.069

Clinical Causes: Genetic predisposition affecting immune system regulation Environmental factors, such as infections or exposure to certain chemicals Immune system dysfunction leading to joint inflammation Other autoimmune processes that target joint tissues

Key Symptoms: Persistent pain in the affected knee Swelling around the joint Stiffness, especially in the morning or after periods of inactivity Warmth and redness over the joint area Reduced range of motion in the affected knee Fatigue and general malaise in some cases

Diagnosis Path: Diagnosing seronegative rheumatoid arthritis involves a combination of medical history assessment, physical examination, and diagnostic tests. Key steps include: - Clinical evaluation for joint swelling, tenderness, and range of motion - Blood tests to rule out other causes, noting the absence of rheumatoid factor (RF) and anti-CCP antibodies - Imaging studies such as X-rays or MRI to identify joint damage or inflammation - Exclusion of other joint disorders like osteoarthritis, gout, or infection Since this form of RA lacks specific blood markers, diagnosis relies heavily on symptom patterns and exclusion of other conditions.

Treatment Protocols: Treatment strategies aim to reduce inflammation, relieve pain, and prevent joint damage. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to manage pain and inflammation - Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, may be prescribed cautiously even in seronegative cases - Corticosteroids for short-term relief of severe inflammation - Physical therapy to maintain joint function and strength - Regular monitoring of symptoms and joint health More recently, biologic agents targeting specific immune pathways have shown benefits in certain cases, though their use depends on individual patient assessments. Early diagnosis and treatment are crucial to preventing joint deterioration.